Paul Bolaji: ACTIVATE Study in Ghana Demonstrates Over 400% Increase in Stroke Thrombolysis
Paul Bolaji, Education Lead (Stroke Services) at Dorset County Hospital NHS Foundation Trust, shared on LinkedIn about a recent article by Priscilla Abrafi Opare-Addo et al, published in Journal of Stroke and Cerebrovascular Diseases, adding:
”Intentional. Innovative. Introspective.
A phenomenal piece of implementation research by Dr Priscilla Abrafi Opare-Addo and team from Ghana demonstrating that acute stroke reperfusion therapies can indeed be improved in Low- and Middle-Income Countries when context-specific barriers are intentionally addressed.
Their ACTIVATE study achieved more than a 400% increase in thrombolysis rates in a tertiary hospital through a multipronged implementation strategy focused on:
- Stroke awareness campaigns
- Protocolised stroke interventions
- Multidisciplinary stroke teamwork
- Financial mitigation strategies
- Streamlined acute stroke pathways
Importantly, this was not merely a clinical intervention study it was implementation science in action: identifying contextual bottlenecks, understanding local realities, and designing pragmatic solutions tailored to the environment.
What stands out is the powerful message that improving acute reperfusion therapy in LMICs is not impossible.
- The barriers are real
- Delayed presentation,
- Limited imaging access,
- Workforce constraints,
- Financial toxicity,
- Fragmented pathways
but they are not insurmountable when tackled systematically.
Kudos to Dr Priscilla Abrafi Opare-Addo and the entire multidisciplinary team.
The hard work, systems thinking, and persistence behind this achievement truly show that this the kind of context-fit innovation and implementation research that Africa and indeed the wider LMIC community needs more of.”
Title: Integrating thrombolysis into routine stroke care in a Ghanaian tertiary hospital, using the implementation research logic model (IRLM) as a guiding framework
Authors: Priscilla Abrafi Opare-Addo, Fred Stephen Sarfo, Chris Oppong, Sheila Adamu, Ishaak Ahmed Yussif, Manolo Agbenorku, Kwasi Ankomah, Kwasi Adjepong Twum, Emmanuel Boadi Attafuah, Akosua Afriyie-Ansah, John Emmanuel Oppong Mensah, Sommik Miilon Duut, Minas Aikins, Alfred Opata, Benedict Kusi Ampofo, Yaa Bema Sarkodie Amankwah, Khabib Abdulai Baba, Serwaa Asare-Bediako, Eno Akua Afriyie Biney, Rexford Adu Gyamfi, José Biller

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026